<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Phys Ther Sci</journal-id><journal-id journal-id-type="iso-abbrev">J Phys Ther Sci</journal-id><journal-id journal-id-type="publisher-id">JPTS</journal-id><journal-title-group><journal-title>Journal of Physical Therapy Science</journal-title></journal-title-group><issn pub-type="ppub">0915-5287</issn><issn pub-type="epub">2187-5626</issn><publisher><publisher-name>The Society of Physical Therapy Science</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26311959</article-id><article-id pub-id-type="pmc">4540854</article-id><article-id pub-id-type="publisher-id">jpts-2015-152</article-id><article-id pub-id-type="doi">10.1589/jpts.27.2225</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Does aerobic exercise affect the hypothalamic-pituitary-adrenal hormonal
response in patients with fibromyalgia syndrome?</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Genc</surname><given-names>Aysun</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref rid="cor1" ref-type="corresp"><sup>*</sup></xref></contrib><contrib contrib-type="author"><name><surname>Tur</surname><given-names>Birkan Sonel</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Aytur</surname><given-names>Yesim Kurtais</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Oztuna</surname><given-names>Derya</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Erdogan</surname><given-names>Murat Faik</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><aff id="aff1"><label>1)</label> Physiotherapy Programme, Ankara University Vocational
School of Haymana, Turkey</aff><aff id="aff2"><label>2)</label> Department of Physical Medicine and Rehabilitation, Ankara
University Faculty of Medicine, Turkey</aff><aff id="aff3"><label>3)</label> Department of Biostatistics, Ankara University Faculty of
Medicine, Turkey</aff><aff id="aff4"><label>4)</label> Department of Endocrinology and Metabolism, Ankara
University Faculty of Medicine, Turkey</aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>Corresponding author. Aysun Genc, Physiotherapy Programme, Ankara University Vocational
School of Haymana: Turan Gunes Bulvari, Park Oran Sitesi, B5/28 06450, Oran, Cankaya,
Ankara, Turkey. (E-mail: <email xlink:href="draysung@yahoo.com">draysung@yahoo.com</email>)</corresp></author-notes><pub-date pub-type="epub"><day>22</day><month>7</month><year>2015</year></pub-date><pub-date pub-type="ppub"><month>7</month><year>2015</year></pub-date><volume>27</volume><issue>7</issue><fpage>2225</fpage><lpage>2231</lpage><history><date date-type="received"><day>25</day><month>2</month><year>2015</year></date><date date-type="accepted"><day>13</day><month>4</month><year>2015</year></date></history><permissions><copyright-statement>2015&#x000a9;by the Society of Physical Therapy Science. Published by IPEC
Inc.</copyright-statement><copyright-year>2015</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/"><license-p>This is an open-access article distributed under the terms of the Creative
Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License. </license-p></license></permissions><abstract><p>[Purpose] The hypothalamic-pituitary-adrenal (HPA) axis in the etiopathogenesis of
fibromyalgia is not clear. This study aimed to analyze the effects of a 6-week aerobic
exercise program on the HPA axis in patients with fibromyalgia and to investigate the
effects of this program on the disease symptoms, patients&#x02019; fitness, disability, and
quality of life. [Subjects and Methods] Fifty fibromyalgia patients were randomized to
Group 1 (stretching and flexibility exercises at home for 6 weeks) and Group 2 (aerobic
exercise three times a week and the same at-home exercises as Group 1 for 6 weeks). Serum
levels of cortisol, adrenocorticotropic hormone, insulin-like growth factor-1, and growth
hormone were analyzed at baseline and at the end of, and 1 hr after an exercise stress
test. [Results] Group 2 showed better improvement in morning stiffness duration and pain.
Growth hormone levels significantly increased after intervention and cortisol levels
significantly decreased at time-time interaction in both groups. No significant
differences in adrenocorticotropic hormone and insulin-like growth factor-1 were found.
[Conclusion] The results of this study seem to support the hypothesis that there is a
dysregulation of the HPA axis in patients with FM, and that a six-week exercise program
can influence symptoms and affect the HPA axis hormones.</p></abstract><kwd-group><title>Key words</title><kwd>Fibromyalgia</kwd><kwd>Aerobic exercise</kwd><kwd>Hypothalamic-pituitary-adrenal axis</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="s1"><title>INTRODUCTION</title><p>Fibromyalgia syndrome (FMS) is a chronic pain disorder that is associated with fatigue,
tender points, sleep disturbances, cognitive dysfunction and mood disorders<xref rid="r1" ref-type="bibr">1</xref><sup>)</sup>. Although the exact cause of the disease is
not known, several theories have been proposed. The role of hypothalamic-pituitary-adrenal
(HPA) axis dysfunction in the etiopathogenesis of FMS has been discussed<xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r3" ref-type="bibr">3</xref>,<xref rid="r4" ref-type="bibr">4</xref><sup>)</sup>. The HPA axis plays a major role in the
regulation of stress responses. It has been shown that, cortisol levels switch from the
normal diurnal cortisol pattern to constant time-independent levels in FMS patients, and
that hormonal levels are low and that they are not suppressed by dexamethasone<xref rid="r5" ref-type="bibr">5</xref><sup>)</sup>. Low serum growth hormone (GH) and
insulin-like growth factor-1 (IGF-1) levels in FMS patients have also been reported<xref rid="r6" ref-type="bibr">6</xref><sup>)</sup>. Exogenic and endogenic stresses, such as
metabolic, physiological, infectious, inflammatory and emotional factors, activate the
neuroendocrine system<xref rid="r7" ref-type="bibr">7</xref><sup>)</sup>; however studies
analyzing the stress responses of HPA axis alterations in FMS patients have reported
conflicting results.</p><p>The management of FMS is difficult, and multifaceted treatment modalities are frequently
required. Usually, the daily activities of patients are limited; thus, their physical and
aerobic performance capacities decline. Aerobic exercise (AE) has positive effects on FMS
through the alleviation of FMS symptoms<xref rid="r8" ref-type="bibr">8</xref>, <xref rid="r9" ref-type="bibr">9</xref><sup>)</sup>. The serum beta endorphin level,
immunoreactivity, and euphoria increase after AE, eliciting positive emotional and mental
effects, better sleep quality and decreased pain sensitivity. It is also well known that
acute exercise is a potent modulator of the release of HPA hormones<xref rid="r10" ref-type="bibr">10</xref><sup>)</sup>. In addition to this, high intensity exercise affects the
HPA axis more than low intensity exercise<xref rid="r11" ref-type="bibr">11</xref><sup>)</sup>. The improvements in the symptoms of FMS after an exercise program
might be partially attributed to amelioration of disorder in the HPA axis<xref rid="r12" ref-type="bibr">12</xref><sup>)</sup>. However, the manner by which exercise can
benefit patients is still unclear<xref rid="r8" ref-type="bibr">8</xref>, <xref rid="r13" ref-type="bibr">13</xref><sup>)</sup>. Unfortunately, studies investigating the
effect of exercise on HPA axis in FMS patients are scarce. Kurtais et al.<xref rid="r14" ref-type="bibr">14</xref><sup>)</sup> analyzed the effects of a single exercise
session on the HPA axis in patients with FMS, and their results of the study suggest that
there might be a hormonal perturbation response to exercise in patients. Accordingly, the
hypothesis of this study was that exercise training might improve HPA axis disturbances in
patients with FMS and further ameliorate symptoms. To investigate this hypothesis, were
investigated the effects of a 6-week AE program on the HPA axis in patients with FMS. Our
secondary aim was to investigate the effects of this program on FMS symptoms, patients&#x02019;
fitness, disability, and quality of life.</p></sec><sec sec-type="methods" id="s2"><title>SUBJECTS AND METHODS</title><p>This was a randomized, controlled study. Fifty-six female FMS patients who were admitted to
the FMS Out-patient Clinic of the Physical Medicine and Rehabilitation Department of our
institution were invited to participate in the study. The subjects had been diagnosed as
having fibromyalgia according to clinicians&#x02019; decisions considering both the 1990 American
College of Rheumatology classification criteria<xref rid="r15" ref-type="bibr">15</xref><sup>)</sup> and clinical findings. Patients were excluded if they had any of
the following: an endocrine, metabolic, infectious, or neurologic disease, cancer,
connective tissue disorder, a cardiac, respiratory, or orthopedic disease that might have
hindered AE, hormonal dysfunction, pregnancy, menopause, or a cognitive function that might
have hampered the assessments. Patients who were receiving any sort of treatment such as
psychological or physical therapy for FMS in the last 3 months and the patients who were in
need of medication for anxiety or depression during the study were also excluded. The
demographic and clinical characteristics were recorded.</p><p>Fifty-four consecutive patients, who were eligible for the study, were randomly assigned to
Group 1 or Group 2 using a sequence of random numbers. Group 1 performed home exercises
consisting of flexibility and stretching exercises twice a day in ten repetitions for 6
weeks. Group 2 performed the same at-home exercise program and an additional AE program
comprised of walking on a treadmill three times a week for 6 weeks.</p><p>An illustrated card depicting flexibility and stretching training programs was given to
patients, and all the motions were demonstrated and described in detail by physicians before
the start of the study. This card had 12 flexibility (trunk, hips, ankle, shoulders, and
wrist) movement and 12 stretching (neck, lateral side, chest, shoulder, arm, triceps,
quadriceps, ankle, calf, hamstring stretch) movement illustrations. Exercise compliance of
all the patients was checked by telephone once a week. In Group 2, each AE session was
planned to last 40&#x02013;50&#x02005;min, including 5&#x02005;min each for the warm-up and cool-down periods. The
exercise intensity was adjusted to achieve a heart rate equivalent to 60&#x02013;75% of the maximum
heart rate. The heart rate was monitored using a pulse oximeter.</p><p>The use of paracetamol, was allowed if necessary; however, NSAIDs utilization was
prohibited during this study since they cause significant changes in the HPA axis<xref rid="r16" ref-type="bibr">16</xref><sup>)</sup>.</p><p>The patients were assessed for pain, tender point count, morning stiffness duration,
fatigue, cardiovascular fitness, functional disability, and health-related quality of life
(HRqOL). These measures were evaluated by the same examiner (AG) at baseline and at the end
of the study.</p><p>Pain was assessed using a 100-mm visual analogue scale (VAS; 0&#x02005;mm = no pain, 100&#x02005;mm = worst
possible pain). A digital tender point examination (tender point count) at the 18 sites
specified in the American College of Rheumatology FMS classification criteria<xref rid="r15" ref-type="bibr">15</xref><sup>)</sup> was performed. The duration of morning
stiffness was recorded in minutes. The sleep quality was assessed using questions including
difficulty in falling asleep (the number of nights/week in which the patient experienced
difficulty in falling asleep), frequent awakening during sleep (0=none, 1=some of the
nights, 2=every night) and quality of sleep (0= good, 1= moderate, 2= unrefreshing).
Functional disability was evaluated using the Fibromyalgia Impact Questionnaire (FIQ)<xref rid="r17" ref-type="bibr">17</xref><sup>)</sup>. The Turkish adaptation of the FIQ with
validity and reliability studies of this scale was conducted by Sarmer et al<xref rid="r18" ref-type="bibr">18</xref><sup>)</sup>. The HRqOL was evaluated using the Turkish
version of the SF-36<xref rid="r19" ref-type="bibr">19</xref>, <xref rid="r20" ref-type="bibr">20</xref><sup>)</sup>. The SF-36 assesses eight dimensions, including physical
functioning, physical role problems, bodily pain, general health perception, vitality,
social functioning, emotional role problems, and mental health.</p><p>An ergospirometric exercise tolerance test was used not only to evaluate cardiovascular
fitness (aerobic capacity) but also to serve as a physiological stressor to evoke HPA
hormonal responses<xref rid="r14" ref-type="bibr">14</xref>, <xref rid="r21" ref-type="bibr">21</xref><sup>)</sup>. Before each test, dynamic respiratory function tests were
performed (Vmax29, Sensormedics, Yorba Linda, CA), a routine procedure of our laboratory, in
order to exclude any major respiratory limitation for exercise, and the forced vital
capacity (FVC), forced expiratory volume in one second (FEV1), FVC/FEV1, and vital capacity
were recorded. The patients were instructed to avoid heavy exercise 24 hours before the test
and to abstain from any food, coffee, tea or cigarette smoking on the morning of the test
day. The ergospirometric exercise tolerance test was conducted on a treadmill using the
modified Bruce protocol. Twelve-lead electrocardiography (Marquette Case I; Marquette,
Milwaukee, WI), blood pressure, and breath-by-breath analysis of respiratory gases (Vmax29,
Sensormedics, Yorba Linda, CA, USA) were recorded during the exercise test. The resting and
maximal heart rates (HR, beats per minute; bpm), exercise duration (minutes), systolic and
diastolic blood pressure (SBP, DBP, mmHg), maximal oxygen consumption during exercise
(VO<sub>2max</sub>, ml/kg/min), oxygen consumption at the anaerobic threshold (AT)
(ml/kg/min), and metabolic equivalent (MET) values were recorded. The ergospirometric
exercise tolerance test was conducted twice for all patients. The objective of the first
test was to determine the peak oxygen consumption (VO<sub>2peak</sub>) and to establish an
AT in both groups so that the second exercise test could be set to a level that was
sufficient to exceed the AT for provoking the HPA axis. Therefore, for all patients, the
ergospirometric exercise test to volitional exhaustion (symptom-limited termination) was
performed at 8.30 a.m. The AT was determined using the V-slope technique on a
VO<sub>2</sub>/VCO<sub>2</sub> plot<xref rid="r22" ref-type="bibr">22</xref><sup>)</sup>.
The second exercise test was performed a couple of days after the first test and at the same
time in the morning. Prior to the second test, blood samples were drawn to measure the
fasting basal levels of GH, IGF-I, adrenocorticotropic hormone (ACTH), and cortisol.
Exercise testing was performed on a treadmill with 12-lead electrocardiography and
respiratory gas analysis was conducted throughout the test. The exercise intensity of each
subject was set above her AT, as guided by the HR and oxygen consumption. The duration of
the exercise was 15 minutes after reaching the AT, which is sufficient to provoke hormonal
responses. Post-exercise blood samples were drawn to measure the levels of GH, ACTH, and
cortisol immediately after the end of the exercise and at 30 and 60 minutes later. Since
IGF-I is not secreted acutely after stimulation, it was only measured at 60 minutes after
the end of exercise. At the end of the 6-week program period, both groups performed the two
exercise tests again. All blood samples were stored at &#x02212;80&#x02005;&#x000b0;C until assayed.</p><p>Plasma ACTH, IGF-1, and GH levels were measured using immunoradiometric assays (Beckman
Coulter, Immunotech, Marseille, France). Serum cortisol levels were also measured by a
radioimmunoassay (Beckman Coulter, Immunotech, Prague, Czech Republic) method.</p><p>Statistical analyses were performed using SPSS 11.5. The frequency (percent) was used as a
descriptive statistic for categorical variables, and the mean &#x000b1; standard deviation [median
(minimum-maximum)] was used for metric variables. To compare the metric variables of two
independent groups, Student&#x02019;s t test or the Mann-Whitney U test was used. The &#x003c7;<sup>2</sup>
test was used to evaluate the differences between groups in categorical variables. To
compare repeated measurements of independent groups, a two-way repeated measures
ANOVA/linear mixed effects model was used to test the effects of time(s), group and their
interactions. When the interaction between time and group was found to be statistically
significant, a Bonferroni corrected one-way repeated measures ANOVA was used for each group
and values of p&#x0003c;0.025 were considered as statistically significant. The linear mixed
effects model analysis was performed for the analysis of nested longitudinal data with
independent groups. In general, p&#x0003c;0.05 was considered as statistically significant.</p><p>This study was approved by the Ethical Committee of our institution. All patients provided
their informed consent and the study was carried out in compliance with the Declaration of
Helsinki.</p></sec><sec sec-type="results" id="s3"><title>RESULTS</title><p>Fifty-four patients who met the inclusion criteria were recruited for this study. During
the study, two patients from both groups were excluded (<xref ref-type="fig" rid="fig_001">Fig. 1</xref><fig orientation="portrait" fig-type="figure" id="fig_001" position="float"><label>Fig. 1.</label><caption><p>Flow chart</p><p>*The reasons for exclusion from the study</p></caption><graphic xlink:href="jpts-27-2225-g001"/></fig>). The mean ages of the patients in Group 1 and Group 2 were 36.9&#x02005;years and
35.1&#x02005;years, respectively. The mean durations of the disease in Group 1 and Group 2 were 62.2
months and 67.4 months, respectively. There was no significant difference between the two
groups with respect to age (p=0.427), duration of disease (p=0.617), or the presence of
comorbid conditions (p=0.463).</p><p>To evaluate pain a visual analog scale was used at the beginning and end of the 6 week
exercise program. Pain decreased significantly in both groups (p=0.008&#x0003c;0.025 for Group 1,
p&#x0003c;0.001 for Group 2), and there was a more significant improvement in Group 2 (p=0.011).
The duration of morning stiffness significantly decreased only in Group 2 (p=0.112&#x0003e;0.025
for Group 1, p=0.001&#x0003c;0.025 for Group 2). The number of tender points, FIQ and sleep
scores were significantly lower in both groups at the end of the study, but there were no
statistically significant differences between the groups (<xref rid="tbl_001" ref-type="table">Table 1</xref><table-wrap id="tbl_001" orientation="portrait" position="float"><label>Table 1.</label><caption><title>Clinical parameters for FMS</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="3" colspan="1"/><th colspan="3" valign="top" align="center" rowspan="1">Factors</th><th colspan="2" valign="top" align="center" rowspan="1">Group 1 (n=25)</th><th colspan="2" valign="top" align="center" rowspan="1">Group 2 (n=25)</th></tr><tr><th colspan="3" rowspan="1"><hr/></th><th colspan="2" rowspan="1"><hr/></th><th colspan="2" rowspan="1"><hr/></th></tr><tr><th valign="middle" align="center" rowspan="1" colspan="1">Group</th><th valign="middle" align="center" rowspan="1" colspan="1">Time</th><th valign="middle" align="center" rowspan="1" colspan="1">Group *Time interaction</th><th valign="middle" align="center" rowspan="1" colspan="1">BE</th><th valign="middle" align="center" rowspan="1" colspan="1">AE</th><th valign="middle" align="center" rowspan="1" colspan="1">BE</th><th valign="middle" align="center" rowspan="1" colspan="1">AE</th></tr></thead><tbody><tr><td align="left" rowspan="2" colspan="1">VAS (0&#x02013;100 mm)</td><td align="center" rowspan="2" colspan="1">0.382</td><td align="center" rowspan="2" colspan="1">&#x0003c;0.001</td><td align="center" rowspan="2" colspan="1">0.011</td><td align="center" rowspan="1" colspan="1">73.96&#x000b1;23.47</td><td align="center" rowspan="1" colspan="1">63.96&#x000b1;19.01</td><td align="center" rowspan="1" colspan="1">76.04&#x000b1;20.07</td><td align="center" rowspan="1" colspan="1">55.56&#x000b1;20.09</td></tr><tr><td align="center" rowspan="1" colspan="1">[80 (10&#x02013;100)]</td><td align="center" rowspan="1" colspan="1">[65 (18&#x02013;95)]</td><td align="center" rowspan="1" colspan="1">[79 (35&#x02013;100)]</td><td align="center" rowspan="1" colspan="1">[52.2 (14&#x02013;100)]</td></tr><tr><td align="left" rowspan="2" colspan="1">Morning stiffness (minute)</td><td align="center" rowspan="2" colspan="1">0.693</td><td align="center" rowspan="2" colspan="1">&#x0003c;0.001</td><td align="center" rowspan="2" colspan="1">0.038</td><td align="center" rowspan="1" colspan="1">47.80&#x000b1;45.53</td><td align="center" rowspan="1" colspan="1">39.80&#x000b1;36.41</td><td align="center" rowspan="1" colspan="1">61.80&#x000b1;59.07</td><td align="center" rowspan="1" colspan="1">35.60&#x000b1;40.35</td></tr><tr><td align="center" rowspan="1" colspan="1">[30 (0&#x02013;180)]</td><td align="center" rowspan="1" colspan="1">[30 (0&#x02013;120)]</td><td align="center" rowspan="1" colspan="1">[60 (0&#x02013;240)]</td><td align="center" rowspan="1" colspan="1">[30 (0&#x02013;150)]</td></tr><tr><td align="left" rowspan="2" colspan="1">Number of tender points (0&#x02013;18)</td><td align="center" rowspan="2" colspan="1">0.506</td><td align="center" rowspan="2" colspan="1">&#x0003c;0.001</td><td align="center" rowspan="2" colspan="1">0.066</td><td align="center" rowspan="1" colspan="1">15.36&#x000b1;2.56</td><td align="center" rowspan="1" colspan="1">13.48&#x000b1;2.99</td><td align="center" rowspan="1" colspan="1">15.68&#x000b1;2.17</td><td align="center" rowspan="1" colspan="1">12.36&#x000b1;2.22</td></tr><tr><td align="center" rowspan="1" colspan="1">[16 (11&#x02013;18)]</td><td align="center" rowspan="1" colspan="1">[14 (6&#x02013;18)]</td><td align="center" rowspan="1" colspan="1">[16 (11&#x02013;18)]</td><td align="center" rowspan="1" colspan="1">[12 (7&#x02013;17)]</td></tr><tr><td align="left" rowspan="2" colspan="1">FIQ score (0&#x02013;100)</td><td align="center" rowspan="2" colspan="1">0.916</td><td align="center" rowspan="2" colspan="1">&#x0003c;0.001</td><td align="center" rowspan="2" colspan="1">0.077</td><td align="center" rowspan="1" colspan="1">63.21&#x000b1;25.21</td><td align="center" rowspan="1" colspan="1">57.26&#x000b1;18.03</td><td align="center" rowspan="1" colspan="1">66.37&#x000b1;22.37</td><td align="center" rowspan="1" colspan="1">52.94&#x000b1;16.05</td></tr><tr><td align="center" rowspan="1" colspan="1">[68 (12&#x02013;100)]</td><td align="center" rowspan="1" colspan="1">[60.1 (14&#x02013;82.1)]</td><td align="center" rowspan="1" colspan="1">[61.3 (31.1&#x02013;100)]</td><td align="center" rowspan="1" colspan="1">[53.6 (25.2&#x02013;76.34)]</td></tr><tr><td align="left" rowspan="2" colspan="1">Sleep score (0&#x02013;11)</td><td align="center" rowspan="2" colspan="1">0.732</td><td align="center" rowspan="2" colspan="1">0.037</td><td align="center" rowspan="2" colspan="1">0.081</td><td align="center" rowspan="1" colspan="1">8.46&#x000b1;3.51</td><td align="center" rowspan="1" colspan="1">8.02&#x000b1;2.91</td><td align="center" rowspan="1" colspan="1">9.41&#x000b1;2.34</td><td align="center" rowspan="1" colspan="1">8.24&#x000b1;3.37</td></tr><tr><td align="center" rowspan="1" colspan="1">[11 (3&#x02013;11)]</td><td align="center" rowspan="1" colspan="1">[11 (0&#x02013;11)]</td><td align="center" rowspan="1" colspan="1">[11 (3&#x02013;11)]</td><td align="center" rowspan="1" colspan="1">[8 (2&#x02013;11)]</td></tr></tbody></table><table-wrap-foot><p>Results are expressed as the mean&#x000b1;SD [median (minimum&#x02013;maximum)]. BE: before exercise;
AE: after exercise; VAS: visual analog scale; FIQ: Fibromyalgia impact questionnaire.
The &#x0201c;group&#x0201d; column shows the main effect of group (home exercise vs. aerobic
exercise), the &#x0201c;time&#x0201d; column shows the main effect of time (before exercise vs. after
exercise), and the &#x0201c;group*time interaction&#x0201d; column shows the interaction between the
groups and the time points.</p></table-wrap-foot></table-wrap>).</p><p>The general health score was lower in Group 1 than in Group 2 (p=0.003), but it showed no
significant time differences. Likewise, there were no significant differences in the other
subscales of SF-36. Significant improvements in the bodily pain (BP) and social functioning
(SF) subscales of the SF-36 were found in both groups (p&#x0003c;0.001 for BP, p=0.039 for SF)
(<xref rid="tbl_002" ref-type="table">Table 2</xref><table-wrap id="tbl_002" orientation="portrait" position="float"><label>Table 2.</label><caption><title>SF-36 health survey norm-based scores</title></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="3" valign="top" align="left" colspan="1"/><th colspan="3" align="center" rowspan="1">Factors</th><th colspan="2" valign="middle" align="center" rowspan="1">Group 1 (n=25)</th><th colspan="2" valign="middle" align="center" rowspan="1">Group 2 (n=25)</th></tr><tr><th colspan="3" rowspan="1"><hr/></th><th colspan="2" rowspan="1"><hr/></th><th colspan="2" rowspan="1"><hr/></th></tr><tr><th align="center" rowspan="1" colspan="1">Group</th><th valign="middle" align="center" rowspan="1" colspan="1">Time</th><th valign="middle" align="center" rowspan="1" colspan="1">Group *Time interaction</th><th valign="middle" align="center" rowspan="1" colspan="1">BE</th><th valign="middle" align="center" rowspan="1" colspan="1">AE</th><th valign="middle" align="center" rowspan="1" colspan="1">BE</th><th align="center" rowspan="1" colspan="1">AE</th></tr></thead><tbody><tr><td align="left" rowspan="2" colspan="1">Physical functioning</td><td align="center" rowspan="2" colspan="1">0.580</td><td align="center" rowspan="2" colspan="1">0.528</td><td align="center" rowspan="2" colspan="1">0.856</td><td align="center" rowspan="1" colspan="1">69.84&#x000b1;24.84</td><td align="center" rowspan="1" colspan="1">71.15&#x000b1;31.45</td><td align="center" rowspan="1" colspan="1">73.29&#x000b1;23.83</td><td align="center" rowspan="1" colspan="1">75.68&#x000b1;28.62</td></tr><tr><td align="center" rowspan="1" colspan="1">[80 (5.5&#x02013;100)]</td><td align="center" rowspan="1" colspan="1">[85 (0&#x02013;100)]</td><td align="center" rowspan="1" colspan="1">[72.2 (0&#x02013;100)]</td><td align="center" rowspan="1" colspan="1">[85 (0&#x02013;100)]</td></tr><tr><td align="left" rowspan="2" colspan="1">Role physical</td><td align="center" rowspan="2" colspan="1">0.741</td><td align="center" rowspan="2" colspan="1">0.077</td><td align="center" rowspan="2" colspan="1">0.248</td><td align="center" rowspan="1" colspan="1">33&#x000b1;44.32</td><td align="center" rowspan="1" colspan="1">36&#x000b1;44.53</td><td align="center" rowspan="1" colspan="1">24&#x000b1;34.97</td><td align="center" rowspan="1" colspan="1">38&#x000b1;38.27</td></tr><tr><td align="center" rowspan="1" colspan="1">[0 (0&#x02013;100)]</td><td align="center" rowspan="1" colspan="1">[0 (0&#x02013;100)]</td><td align="center" rowspan="1" colspan="1">[0 (0&#x02013;100)]</td><td align="center" rowspan="1" colspan="1">[25 (0&#x02013;100)]</td></tr><tr><td align="left" rowspan="2" colspan="1">Bodily pain</td><td align="center" rowspan="2" colspan="1">0.517</td><td align="center" rowspan="2" colspan="1">&#x0003c;0.001</td><td align="center" rowspan="2" colspan="1">0.300</td><td align="center" rowspan="1" colspan="1">31.74&#x000b1;21.1</td><td align="center" rowspan="1" colspan="1">38.52&#x000b1;21.16</td><td align="center" rowspan="1" colspan="1">32.52&#x000b1;17.48</td><td align="center" rowspan="1" colspan="1">44.48&#x000b1;20.97</td></tr><tr><td align="center" rowspan="1" colspan="1">[41 (0&#x02013;67.5)]</td><td align="center" rowspan="1" colspan="1">[31 (0&#x02013;84)]</td><td align="center" rowspan="1" colspan="1">[32.5 (0&#x02013;62)]</td><td align="center" rowspan="1" colspan="1">[45 (0&#x02013;74)]</td></tr><tr><td align="left" rowspan="2" colspan="1">General health</td><td align="center" rowspan="2" colspan="1">0.003</td><td align="center" rowspan="2" colspan="1">0.103</td><td align="center" rowspan="2" colspan="1">0.596</td><td align="center" rowspan="1" colspan="1">24.84&#x000b1;12.98</td><td align="center" rowspan="1" colspan="1">30&#x000b1;16.68</td><td align="center" rowspan="1" colspan="1">42.36&#x000b1;23.28</td><td align="center" rowspan="1" colspan="1">45.48&#x000b1;24.74</td></tr><tr><td align="center" rowspan="1" colspan="1">[25 (0&#x02013;55)]</td><td align="center" rowspan="1" colspan="1">[25 (5&#x02013;70)]</td><td align="center" rowspan="1" colspan="1">[42 (0&#x02013;92)]</td><td align="center" rowspan="1" colspan="1">[40 (5&#x02013;92)]</td></tr><tr><td align="left" rowspan="2" colspan="1">Physical component summary</td><td align="center" rowspan="2" colspan="1">0.993</td><td align="center" rowspan="2" colspan="1">0.842</td><td align="center" rowspan="2" colspan="1">0.102</td><td align="center" rowspan="1" colspan="1">42.56&#x000b1;18.89</td><td align="center" rowspan="1" colspan="1">39.95&#x000b1;8.91</td><td align="center" rowspan="1" colspan="1">39.57&#x000b1;8.11</td><td align="left" rowspan="1" colspan="1">42.89&#x000b1;10.18</td></tr><tr><td align="center" rowspan="1" colspan="1">[38.7 (24.7&#x02013;100)]</td><td align="center" rowspan="1" colspan="1">[38.8 (24.4&#x02013;55.1)]</td><td align="center" rowspan="1" colspan="1">[40 (19.5&#x02013;51.6)]</td><td align="center" rowspan="1" colspan="1">[44.1 (19.9&#x02013;57.5)]</td></tr><tr><td align="left" rowspan="2" colspan="1">Vitality</td><td align="center" rowspan="2" colspan="1">0.154</td><td align="center" rowspan="2" colspan="1">0.063</td><td align="center" rowspan="2" colspan="1">0.411</td><td align="center" rowspan="1" colspan="1">25.4&#x000b1;18.93</td><td align="center" rowspan="1" colspan="1">27.6&#x000b1;18.15</td><td align="center" rowspan="1" colspan="1">30&#x000b1;12.08</td><td align="center" rowspan="1" colspan="1">35.60&#x000b1;17.99</td></tr><tr><td align="center" rowspan="1" colspan="1">[20 (0&#x02013;70)]</td><td align="center" rowspan="1" colspan="1">[25 (10&#x02013;70)]</td><td align="center" rowspan="1" colspan="1">[25 (15&#x02013;65)]</td><td align="center" rowspan="1" colspan="1">[40 (0&#x02013;65)]</td></tr><tr><td align="left" rowspan="2" colspan="1">Social functioning</td><td align="center" rowspan="2" colspan="1">0.441</td><td align="center" rowspan="2" colspan="1">0.039</td><td align="center" rowspan="2" colspan="1">0.311</td><td align="center" rowspan="1" colspan="1">45.5&#x000b1;26.24</td><td align="center" rowspan="1" colspan="1">49&#x000b1;23.08</td><td align="center" rowspan="1" colspan="1">47&#x000b1;24.01</td><td align="center" rowspan="1" colspan="1">57&#x000b1;23.96</td></tr><tr><td align="center" rowspan="1" colspan="1">[50 (0&#x02013;100)]</td><td align="center" rowspan="1" colspan="1">[50 (0&#x02013;87.5)]</td><td align="center" rowspan="1" colspan="1">[50 (12.5&#x02013;100)]</td><td align="center" rowspan="1" colspan="1">[62.5 (0&#x02013;100)]</td></tr><tr><td align="left" rowspan="2" colspan="1">Role emotional</td><td align="center" rowspan="2" colspan="1">0.741</td><td align="center" rowspan="2" colspan="1">0.167</td><td align="center" rowspan="2" colspan="1">0.256</td><td align="center" rowspan="1" colspan="1">28&#x000b1;43.76</td><td align="center" rowspan="1" colspan="1">29.32&#x000b1;40.04</td><td align="center" rowspan="1" colspan="1">25.33&#x000b1;35.07</td><td align="center" rowspan="1" colspan="1">38.67&#x000b1;40.47</td></tr><tr><td align="center" rowspan="1" colspan="1">[0 (0&#x02013;100)]</td><td align="center" rowspan="1" colspan="1">[0 (0&#x02013;100)]</td><td align="center" rowspan="1" colspan="1">[0 (0&#x02013;100)]</td><td align="center" rowspan="1" colspan="1">[33.3 (0&#x02013;100)]</td></tr><tr><td align="left" rowspan="2" colspan="1">Mental health</td><td align="center" rowspan="2" colspan="1">0.191</td><td align="center" rowspan="2" colspan="1">0.537</td><td align="center" rowspan="2" colspan="1">0.723</td><td align="center" rowspan="1" colspan="1">40.64&#x000b1;24.07</td><td align="center" rowspan="1" colspan="1">41.12&#x000b1;18.46</td><td align="center" rowspan="1" colspan="1">46.24&#x000b1;14.15</td><td align="center" rowspan="1" colspan="1">48.01&#x000b1;12.27</td></tr><tr><td align="center" rowspan="1" colspan="1">[40 (8&#x02013;90)]</td><td align="center" rowspan="1" colspan="1">[40 (12&#x02013;84)]</td><td align="center" rowspan="1" colspan="1">[44 (16&#x02013;92)]</td><td align="center" rowspan="1" colspan="1">[48 (24&#x02013;88)]</td></tr><tr><td align="left" rowspan="2" colspan="1">Mental component summary</td><td align="center" rowspan="2" colspan="1">0.479</td><td align="center" rowspan="2" colspan="1">0.202</td><td align="center" rowspan="2" colspan="1">0.154</td><td align="center" rowspan="1" colspan="1">30.98&#x000b1;13.26</td><td align="center" rowspan="1" colspan="1">30.80&#x000b1;9.35</td><td align="center" rowspan="1" colspan="1">31.18&#x000b1;8.75</td><td align="center" rowspan="1" colspan="1">34.35&#x000b1;8.47</td></tr><tr><td align="center" rowspan="1" colspan="1">[25.8 (15.4&#x02013;62)]</td><td align="center" rowspan="1" colspan="1">[27.7 (19.5&#x02013;54.4)]</td><td align="center" rowspan="1" colspan="1">[29.3 (19.2&#x02013;59.7)]</td><td align="center" rowspan="1" colspan="1">[33.4 (19.4&#x02013;57.1)]</td></tr></tbody></table><table-wrap-foot><p>Results are expressed as the mean&#x000b1;SD [median (minimum&#x02013;maximum)]. BE: before exercise;
AE: after exercise The &#x0201c;group&#x0201d; column shows the main effect of group (home exercise
vs. aerobic exercise), the &#x0201c;time&#x0201d; column shows the main effect of time (before
exercise vs. after exercise), and the &#x0201c;group*time interaction&#x0201d; column shows the
interaction between the groups and the time points.</p></table-wrap-foot></table-wrap>).</p><p>Pulmonary function tests were within normal limits for all patients. Regarding the exercise
test parameters, the overall difference between the groups was significant (mean score 13.75
and 15.33 for group 1 and 2, respectively) (p&#x0003c;0.001) and the duration of the exercise
test after the exercise program significantly increased in both groups (p=0.002). The
resting heart rate decreased after the exercise program in a statistically significant
manner (p=0.006). As shown at <xref rid="tbl_003" ref-type="table">Table
3</xref><table-wrap id="tbl_003" orientation="portrait" position="float"><label>Table 3.</label><caption><title>Values of exercise test parameters by group</title></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="3" valign="top" align="left" colspan="1"/><th colspan="3" align="center" rowspan="1">Factors</th><th colspan="2" valign="middle" align="center" rowspan="1">Group 1 (n=25)</th><th colspan="2" valign="middle" align="center" rowspan="1">Group 2 (n=25)</th></tr><tr><th colspan="3" rowspan="1"><hr/></th><th colspan="2" rowspan="1"><hr/></th><th colspan="2" rowspan="1"><hr/></th></tr><tr><th align="center" rowspan="1" colspan="1">Group</th><th valign="middle" align="center" rowspan="1" colspan="1">Time</th><th valign="middle" align="center" rowspan="1" colspan="1">Group *Time interaction</th><th valign="middle" align="center" rowspan="1" colspan="1">BE</th><th valign="middle" align="center" rowspan="1" colspan="1">AE</th><th valign="middle" align="center" rowspan="1" colspan="1">BE</th><th align="center" rowspan="1" colspan="1">AE</th></tr></thead><tbody><tr><td align="left" rowspan="2" colspan="1">The duration of exercise (minute)</td><td align="center" rowspan="2" colspan="1">&#x0003c;0.001<break/>(Means for group 1: 13.75 group 2:
15.33)</td><td align="center" rowspan="2" colspan="1">0.002</td><td align="center" rowspan="2" colspan="1">0.421</td><td align="center" valign="middle" rowspan="1" colspan="1">13.39&#x000b1;1.64</td><td align="center" valign="middle" rowspan="1" colspan="1">14.1&#x000b1;1.23</td><td align="center" rowspan="1" colspan="1">14.83&#x000b1;1.61</td><td align="center" rowspan="1" colspan="1">16.03&#x000b1;1.56</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[13.3 (9.7&#x02013;16.4)]</td><td align="center" valign="middle" rowspan="1" colspan="1">[14.2 (11.3&#x02013;15.9)]</td><td align="center" rowspan="1" colspan="1">[15.4 (11.3&#x02013;17.2)]</td><td align="center" rowspan="1" colspan="1">[15.8 (12.5&#x02013;20)]</td></tr><tr><td align="left" rowspan="2" colspan="1">VO<sub>2</sub>maximum (ml/kg/min)</td><td align="center" rowspan="2" colspan="1">&#x0003c;0.001<break/>(Means for group 1: 24.19 group 2:
29.26)</td><td align="center" rowspan="2" colspan="1">0.704</td><td align="center" rowspan="2" colspan="1">0.583</td><td align="center" valign="middle" rowspan="1" colspan="1">24.53&#x000b1;3.72</td><td align="center" valign="middle" rowspan="1" colspan="1">24.09&#x000b1;4.87</td><td align="center" rowspan="1" colspan="1">30.11&#x000b1;3.90</td><td align="center" rowspan="1" colspan="1">29.14&#x000b1;8.12</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[24.8 (14.7&#x02013;31.1)]</td><td align="center" valign="middle" rowspan="1" colspan="1">[23.7 (12.4&#x02013;32.6)]</td><td align="center" rowspan="1" colspan="1">[29.5 (22.1&#x02013;40.3)]</td><td align="center" rowspan="1" colspan="1">[28 (15.6&#x02013;53.5)]</td></tr><tr><td align="left" rowspan="2" colspan="1">O<sub>2</sub> consumption in AT (L/min)</td><td align="center" rowspan="2" colspan="1">0.727</td><td align="center" rowspan="2" colspan="1">0.283</td><td align="center" rowspan="2" colspan="1">0.320</td><td align="center" valign="middle" rowspan="1" colspan="1">1.02&#x000b1;0.36</td><td align="center" valign="middle" rowspan="1" colspan="1">1.02&#x000b1;0.22</td><td align="center" rowspan="1" colspan="1">1.09&#x000b1;0.20</td><td align="center" rowspan="1" colspan="1">1.02&#x000b1;0.19</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[1 (0.3&#x02013;1.6)]</td><td align="center" valign="middle" rowspan="1" colspan="1">[1 (0.7&#x02013;1.5)]</td><td align="center" rowspan="1" colspan="1">[1.1 (0.6&#x02013;1.5)]</td><td align="center" rowspan="1" colspan="1">[1 (0.7&#x02013;1.5)]</td></tr><tr><td align="left" rowspan="2" colspan="1">Resting heart rate (BPM)</td><td align="center" rowspan="2" colspan="1">0.843</td><td align="center" rowspan="2" colspan="1">0.006</td><td align="center" rowspan="2" colspan="1">0.441</td><td align="center" valign="middle" rowspan="1" colspan="1">95.25&#x000b1;19.20</td><td align="center" valign="middle" rowspan="1" colspan="1">91.55&#x000b1;20.61</td><td align="center" rowspan="1" colspan="1">95.79&#x000b1;16.19</td><td align="center" rowspan="1" colspan="1">88.42&#x000b1;13.03</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[94.5 (63&#x02013;158)]</td><td align="center" valign="middle" rowspan="1" colspan="1">[86.5 (62&#x02013;153)]</td><td align="center" rowspan="1" colspan="1">[99 (73&#x02013;121)]</td><td align="center" rowspan="1" colspan="1">[83.5 (69&#x02013;115)]</td></tr><tr><td align="left" rowspan="2" colspan="1">Maximal heart rate (BPM)</td><td align="center" rowspan="2" colspan="1">0.509</td><td align="center" rowspan="2" colspan="1">0.136</td><td align="center" rowspan="2" colspan="1">0.117</td><td align="center" valign="middle" rowspan="1" colspan="1">158.8&#x000b1;20.23</td><td align="center" valign="middle" rowspan="1" colspan="1">157.5&#x000b1;20.15</td><td align="center" rowspan="1" colspan="1">165.79&#x000b1;15.05</td><td align="center" rowspan="1" colspan="1">156.63&#x000b1;21.88</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[165 (124&#x02013;189)]</td><td align="center" valign="middle" rowspan="1" colspan="1">[155.5 (123&#x02013;196)]</td><td align="center" rowspan="1" colspan="1">[164 (134&#x02013;188)]</td><td align="center" rowspan="1" colspan="1">[162.5 (109&#x02013;192)]</td></tr><tr><td align="left" rowspan="2" colspan="1">Systolic blood pressure (mmHg)</td><td align="center" rowspan="2" colspan="1">0.037<break/>(Means for group 1: 115 group 2: 109.1)</td><td align="center" rowspan="2" colspan="1">0.692</td><td align="center" rowspan="2" colspan="1">0.883</td><td align="center" valign="middle" rowspan="1" colspan="1">114.5&#x000b1;12.76</td><td align="center" valign="middle" rowspan="1" colspan="1">114.5&#x000b1;8.87</td><td align="center" rowspan="1" colspan="1">108.54&#x000b1;11.18</td><td align="center" rowspan="1" colspan="1">109.58&#x000b1;11.6</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[115 (100&#x02013;130)]</td><td align="center" valign="middle" rowspan="1" colspan="1">[115 (100&#x02013;130)]</td><td align="center" rowspan="1" colspan="1">[110 (90&#x02013;140)]</td><td align="center" rowspan="1" colspan="1">[110 (90&#x02013;130)]</td></tr><tr><td align="left" rowspan="2" colspan="1">Diastolic blood pressure (mmHg)</td><td align="center" rowspan="2" colspan="1">0.076</td><td align="center" rowspan="2" colspan="1">0.855</td><td align="center" rowspan="2" colspan="1">0.503</td><td align="center" valign="middle" rowspan="1" colspan="1">76.25&#x000b1;8.87</td><td align="center" valign="middle" rowspan="1" colspan="1">77.5&#x000b1;6.59</td><td align="center" rowspan="1" colspan="1">73.75&#x000b1;7.7</td><td align="center" rowspan="1" colspan="1">72.5&#x000b1;9.78</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[80 (60&#x02013;90)]</td><td align="center" valign="middle" rowspan="1" colspan="1">[80 (70&#x02013;90)]</td><td align="center" rowspan="1" colspan="1">[70 (60&#x02013;90)]</td><td align="center" rowspan="1" colspan="1">[70 (60&#x02013;90)]</td></tr><tr><td align="left" rowspan="2" colspan="1">MET</td><td align="center" rowspan="2" colspan="1">0.027 (Means for group 1: 9.12 group 2: 10.28)</td><td align="center" rowspan="2" colspan="1">0.390</td><td align="center" rowspan="2" colspan="1">0.739</td><td align="center" valign="middle" rowspan="1" colspan="1">9.13&#x000b1;1.88</td><td align="center" valign="middle" rowspan="1" colspan="1">9.31&#x000b1;2.1</td><td align="center" rowspan="1" colspan="1">10.21&#x000b1;1.55</td><td align="center" rowspan="1" colspan="1">10.56&#x000b1;2.59</td></tr><tr><td align="center" rowspan="1" colspan="1">[10.1 (4.4&#x02013;11.6)]</td><td align="center" valign="middle" rowspan="1" colspan="1">[9.5 (4.4&#x02013;12)]</td><td align="center" rowspan="1" colspan="1">[9.8 (6.9&#x02013;12.1)]</td><td align="center" rowspan="1" colspan="1">[11.8 (4.1&#x02013;14.8)]</td></tr></tbody></table><table-wrap-foot><p>Results are expressed as the mean&#x000b1;SD [median (minimum-maximum)]. BE: before exercise;
AE: after exercise; AT: anaerobic threshold; BPM: beats per minute; MET: metabolic
equivalent. The &#x0201c;group&#x0201d; column shows the main effect of group (home exercise vs.
aerobic exercise), the &#x0201c;time&#x0201d; column shows the main effect of time (before exercise
vs. after exercise), and the &#x0201c;group*time interaction&#x0201d; column shows the interaction
between the groups and the time points.</p></table-wrap-foot></table-wrap>, there were no statistically significant differences before and after the
exercise program in either group in VO<sub>2max</sub>, O<sub>2</sub> consumption at AT,
maximal HR, SBP, DBP, or MET.</p><p>The time effect for before and after the exercise program (p=0.025) and the time-time
interaction (before and after interaction with basal, 1st and 2nd measurements) (p=0.005)
were statistically significant for the GH levels of both groups. The post-hoc comparisons
showed that only the difference between the basal and 2nd measurements in the time period of
before the exercise program was significant (p=0.003). The mean of the 2nd measurement was
higher than the basal measurement (<xref rid="tbl_004" ref-type="table">Table
4</xref><table-wrap id="tbl_004" orientation="portrait" position="float"><label>Table 4.</label><caption><title>Growth hormone (mIU/L) levels</title></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="3" valign="top" align="left" colspan="1"/><th colspan="3" align="center" rowspan="1">BE</th><th colspan="3" valign="middle" align="center" rowspan="1">AE</th></tr><tr><th colspan="3" rowspan="1"><hr/></th><th colspan="3" rowspan="1"><hr/></th></tr><tr><th align="center" rowspan="1" colspan="1">Basal</th><th valign="middle" align="center" rowspan="1" colspan="1">1st measurement</th><th valign="middle" align="center" rowspan="1" colspan="1">2nd measurement</th><th valign="middle" align="center" rowspan="1" colspan="1">Basal</th><th valign="middle" align="center" rowspan="1" colspan="1">1st measurement</th><th align="center" rowspan="1" colspan="1">2nd measurement</th></tr></thead><tbody><tr><td align="left" rowspan="2" colspan="1">Group 1</td><td align="center" rowspan="1" colspan="1">2.81&#x000b1;6.37</td><td align="center" rowspan="1" colspan="1">2.89&#x000b1;4.73</td><td align="center" valign="middle" rowspan="1" colspan="1">6.79&#x000b1;8.33</td><td align="center" valign="middle" rowspan="1" colspan="1">9.61&#x000b1;12.41</td><td align="center" rowspan="1" colspan="1">5.64&#x000b1;13.7</td><td align="center" rowspan="1" colspan="1">5.41&#x000b1;11.38</td></tr><tr><td align="center" rowspan="1" colspan="1">[0.6 (0&#x02013;28.2)]</td><td align="center" rowspan="1" colspan="1">[1.3 (0&#x02013;21.6)]</td><td align="center" valign="middle" rowspan="1" colspan="1">[2.9 (0.2&#x02013;32.4)]</td><td align="center" valign="middle" rowspan="1" colspan="1">[4 (0.3&#x02013;56.3)]</td><td align="center" rowspan="1" colspan="1">[0.8 (0&#x02013;65.8)]</td><td align="center" rowspan="1" colspan="1">[2 (0&#x02013;56.7)]</td></tr><tr><td align="left" rowspan="2" colspan="1">Group 2</td><td align="center" rowspan="1" colspan="1">1.27&#x000b1;2.29</td><td align="center" rowspan="1" colspan="1">4.9&#x000b1;8.66</td><td align="center" valign="middle" rowspan="1" colspan="1">6.49&#x000b1;8.22</td><td align="center" valign="middle" rowspan="1" colspan="1">8.64&#x000b1;10.27</td><td align="center" rowspan="1" colspan="1">3.89&#x000b1;6.97</td><td align="center" rowspan="1" colspan="1">6.06&#x000b1;8.96</td></tr><tr><td align="center" rowspan="1" colspan="1">[0.7 (0&#x02013;11.1)]</td><td align="center" rowspan="1" colspan="1">[0.7 (0.1&#x02013;31.4)]</td><td align="center" valign="middle" rowspan="1" colspan="1">[1.7 (0.3&#x02013;26.1)]</td><td align="center" valign="middle" rowspan="1" colspan="1">[4.4 (0.2&#x02013;30.9)]</td><td align="center" rowspan="1" colspan="1">[0.7 (0&#x02013;22.2)]</td><td align="center" rowspan="1" colspan="1">[1.5 (0.1&#x02013;30.8)]</td></tr><tr><td align="left" rowspan="2" colspan="1">Overall</td><td align="center" rowspan="1" colspan="1">2.04&#x000b1;4.8</td><td align="center" rowspan="1" colspan="1">3.89&#x000b1;6.98</td><td align="center" valign="middle" rowspan="1" colspan="1">6.64&#x000b1;8.19</td><td align="center" valign="middle" rowspan="1" colspan="1">9.13&#x000b1;11.28</td><td align="center" rowspan="1" colspan="1">4.77&#x000b1;10.79</td><td align="center" rowspan="1" colspan="1">5.74&#x000b1;10.14</td></tr><tr><td align="center" rowspan="1" colspan="1">[0.6 (0&#x02013;28.2)]</td><td align="center" rowspan="1" colspan="1">[0.8 (0&#x02013;31.4)]</td><td align="center" rowspan="1" colspan="1">[2.3 (0.2&#x02013;32.4)]</td><td align="center" valign="middle" rowspan="1" colspan="1">[4.1 (0.2&#x02013;56.3)]</td><td align="center" rowspan="1" colspan="1">[0.7 (0&#x02013;65.8)]</td><td align="center" rowspan="1" colspan="1">[2 (0&#x02013;56.7)]</td></tr></tbody></table><table-wrap-foot><p>Results are expressed as the mean&#x000b1;SD [median (minimum&#x02013;maximum)]. BE: before exercise;
AE: after exercise</p></table-wrap-foot></table-wrap>). For the cortisol levels, there were significant differences for the time
effect of the basal, 1st and 2nd measurements (p=0.014) in both groups. Post-hoc comparisons
indicated that the basal measurements (mean&#x000b1;SD: 158.22&#x000b1;35.76&#x02005;nmol/l) were higher than the
1st measurements (mean&#x000b1;SD: 141.17&#x000b1;29.46&#x02005;nmol/l) (p=0.012). There were no significant
differences in ACTH and IGF-1 regarding either the time effect or between-group effects.</p></sec><sec sec-type="discussion" id="s4"><title>DISCUSSION</title><p>Exercise has been fully recognized as an important part of FMS treatment following the
European League against Rheumatism (EULAR) recommendations for the management of FMS
syndrome<xref rid="r23" ref-type="bibr">23</xref><sup>)</sup>. Exercise at
moderate-to-high intensity results in better improvements in functional capacity and in
level of activity limitations<xref rid="r24" ref-type="bibr">24</xref><sup>)</sup>. The
effects of aerobic, progressive-resistance stretching and flexibility exercises on FMS
patients have been analyzed by several studies. Some of these studies demonstrated that AE
has positive effects on sleep, quality of life, self-esteem, depression, pain, and some
exercise test parameters<xref rid="r12" ref-type="bibr">12</xref>, <xref rid="r24" ref-type="bibr">24</xref><sup>)</sup>. Bircan et al.<xref rid="r25" ref-type="bibr">25</xref><sup>)</sup> compared the effects of AE with a muscle-strengthening program, and
found that both exercise modalities were similarly effective at improving symptoms, tender
point count, fitness, depression, and quality of life. On the other hand, Mengshoel et
al.<xref rid="r26" ref-type="bibr">26</xref><sup>)</sup> found that AE did not show any
advantages over no exercise treatment for the physical functions of FMS patients. In the
present study, AE was determined to be superior to the stretching and flexibility exercises
in relation to pain and morning stiffness duration. Although stretching and flexibility
exercise was performed daily, it was well tolerated by both groups. This may have been
because exercises were divided into two daily sessions with low numbers of repetitions. All
clinical parameters of FMS except morning stiffness duration (number of tender points, FIQ
score, pain levels, and length of exercise), the BP and SF subscales of the SF-36, and
resting heart rate improved similarly with both exercise programs.</p><p>Approximately one third of FMS patients are estimated to suffer from GH deficiency. This
condition can lead to reduced IGF-1<xref rid="r6" ref-type="bibr">6</xref><sup>)</sup>. Ross
et al. suggested that GH dysfunction was associated with increased pain and poor muscle
performance in FMS patients<xref rid="r27" ref-type="bibr">27</xref><sup>)</sup>. Nearly
fifty percent of GH secretion occurs during the third and fourth non-REM sleep stages<xref rid="r28" ref-type="bibr">28</xref><sup>)</sup>, and FMS patients have non-REM sleep
disturbances<xref rid="r29" ref-type="bibr">29</xref><sup>)</sup>. This may be one of the
reasons why there are low levels of these hormones in FMS patients. Furthermore, there is
not always a correlation between GH and IGF-1 release. It is well known that an exercise
intensity of 25% VO<sub>2max</sub> increases GH levels<xref rid="r10" ref-type="bibr">10</xref><sup>)</sup>. Exercise is believed to stimulate GH release via cholinergic
activation, and in acute stress conditions, exercise first enhances growth hormone releasing
hormone (GHRH), which then triggers an increase in GH levels<xref rid="r30" ref-type="bibr">30</xref><sup>)</sup>. On the other hand, some authors have reported there are no
significant differences in GH and IGF-1 values between FMS patients and healthy control
groups<xref rid="r31" ref-type="bibr">31</xref>, <xref rid="r32" ref-type="bibr">32</xref><sup>)</sup>. The reasons for these discrepancies might be due to the pulsatile
release of GH and/or differences in the duration of disease and/or chronic stress level<xref rid="r14" ref-type="bibr">14</xref><sup>)</sup>. As for IGF-1, regular exercise is
expected to increase the resting level of the hormone in healthy individuals<xref rid="r33" ref-type="bibr">33</xref><sup>)</sup>, but Jones et al.<xref rid="r34" ref-type="bibr">34</xref><sup>)</sup> reported there was no increase in patients with FMS who
exercised regularly for a long time. In our study, GH levels increased in all patients after
a 6-week exercise program and AE was not superior to flexibility and stretching exercises
regarding the changes in GH levels. Moreover; IGF-1 levels were not changed by the exercise
program, and there was no correlation between GH and IGF-1 levels. This finding was in
agreement with previous studies. Lack of changes in IGF-1 levels with exercise suggests the
existence of a disorder in the hypothalamus-GH-IGF-1 axis in FMS patients.</p><p>If exercise intensity reaches to 30&#x02013;40% of VO<sub>2max,</sub> or if an individual exercises
over the anaerobic threshold, ACTH also increases, and after a 10-minute interval, the
cortisol level also increases. The critical exercise level that triggers cortisol release is
60% of VO<sub>2max</sub>. Low-intensity exercises may lead to a decrease in blood cortisol
levels by increasing clearance<xref rid="r10" ref-type="bibr">10</xref><sup>)</sup>. Several
stimulating agents such as GHRH, luteinizing hormone releasing homone, corticotropin
releasing hormone, clonidine, levodopa, metyrapone, exercise, or several tests such as the
dexamethasone suppression test, or the insulin tolerance test have been used to analyze
hormonal changes in FMS patients by many studies<xref rid="r4" ref-type="bibr">4</xref>,
<xref rid="r14" ref-type="bibr">14</xref>, <xref rid="r27" ref-type="bibr">27</xref>,
<xref rid="r33" ref-type="bibr">33</xref>,<xref rid="r34" ref-type="bibr">34</xref>,<xref rid="r35" ref-type="bibr">35</xref>,<xref rid="r36" ref-type="bibr">36</xref>,<xref rid="r37" ref-type="bibr">37</xref>,<xref rid="r38" ref-type="bibr">38</xref><sup>)</sup>.
The ACTH and cortisol responses to these stimulants are somewhat conflicting. Increased
basal cortisol levels were reported by one study<xref rid="r39" ref-type="bibr">39</xref><sup>)</sup>, whereas other studies reported decreased 24-hour urinary free
cortisol and low morning cortisol release in fibromyalgia<xref rid="r2" ref-type="bibr">2</xref>, <xref rid="r40" ref-type="bibr">40</xref><sup>)</sup>. Normal 24-hour cortisol
and diurnal patterns of ACTH and cortisol secretion have been reported as well<xref rid="r38" ref-type="bibr">38</xref>, <xref rid="r41" ref-type="bibr">41</xref>, <xref rid="r42" ref-type="bibr">42</xref><sup>)</sup>. In the present study, while no
significant difference was detected in the ACTH levels after the exercise program, cortisol
levels significantly decreased with only a time effect. Therefore, the proposed this
discordancy in the HPA axis may be associated with insufficient exercise intensity and/or
duration.</p><p>The main limitation of this study was short exercise duration, since it has been reported
that the positive effects of aerobic exercise become apparent from the 6th week of
exercise<xref rid="r43" ref-type="bibr">43</xref><sup>)</sup>. Extension of the exercise
period to 8&#x02013;12 weeks would possibly allow better monitoring of the effects of exercise. The
lack of increase in VO<sub>2max</sub> levels after the 6-week exercise program in both
groups is possibly a result of insufficient exercise intensity during the intervention
period. There may be several reasons for this such as: insufficient pain relief, short
exercise time, and/or mild-moderate exercise intensity. Furthermore, it is known that
patients with FMS cannot perform high intensity exercises due to pain and tiredness. Only
the use of paracetamol was allowed during this study because NSAIDs utilization can cause
significant changes in the HPA axis. Insufficient pain relief may have resulted in decreased
exercise tolerance and discordance in HPA axis hormones. To relieve pain and increase
exercise capacity pharmacological agents, physical treatment, biofeedback and cognitive
behavioral therapy should be started before all treatments, and exercise programs should be
started afterwards to soothe pain and fatigue.</p><p>The findings of the present study, especially the absence of correlation between GH and
IGF-1, and between ACTH and cortisol, seem to support our hypothesis of a perturbation of
the HPA axis resulting from exercise by FMS patients; however, they do not exactly support
our assumption that this program would provide specific effects on the HPA axis, other than
improvement of FMS symptoms. The increase in GH observed in this study might indicate a
possible link between them. Nonetheless, the findings do verify our hypothesis that exercise
can decrease FMS symptoms. Confirmation of this hypothesis was our secondary objective. AE
programs with stretching and flexibility exercises were found to be similarly effective with
regard to many of the clinical parameters assessed.</p><p>It is our belief that more accurate findings can be obtained by randomized controlled
studies of larger samples and if possible more prolonged or higher intensity exercise.</p></sec></body><back><ack><p>We thank our laboratory staff Serpil Okyar, PT, for her valuable help in testing study
subjects.</p></ack><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group><name><surname>Bennett</surname><given-names>RM</given-names></name><name><surname>Jones</surname><given-names>J</given-names></name><name><surname>Turk</surname><given-names>DC</given-names></name><etal>et al.</etal></person-group>: <article-title>An internet survey of 2,596 people with
fibromyalgia</article-title>. <source>BMC Musculoskelet Disord</source>,
<year>2007</year>, <volume>8</volume>: <fpage>27</fpage>. <pub-id pub-id-type="pmid">17349056</pub-id></mixed-citation></ref><ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group><name><surname>Crofford</surname><given-names>LJ</given-names></name><name><surname>Pillemer</surname><given-names>SR</given-names></name><name><surname>Kalogeras</surname><given-names>KT</given-names></name><etal>et al.</etal></person-group>: <article-title>Hypothalamic-pituitary-adrenal axis perturbations in
patients with fibromyalgia</article-title>. <source>Arthritis Rheum</source>,
<year>1994</year>, <volume>37</volume>: <fpage>1583</fpage>&#x02013;<lpage>1592</lpage>.
<pub-id pub-id-type="pmid">7980669</pub-id></mixed-citation></ref><ref id="r3"><label>3</label><mixed-citation publication-type="journal"><person-group><name><surname>Adler</surname><given-names>GK</given-names></name><name><surname>Kinsley</surname><given-names>BT</given-names></name><name><surname>Hurwitz</surname><given-names>S</given-names></name><etal>et al.</etal></person-group>: <article-title>Reduced hypothalamic-pituitary and sympathoadrenal
responses to hypoglycemia in women with fibromyalgia syndrome</article-title>.
<source>Am J Med</source>, <year>1999</year>, <volume>106</volume>:
<fpage>534</fpage>&#x02013;<lpage>543</lpage>. <pub-id pub-id-type="pmid">10335725</pub-id></mixed-citation></ref><ref id="r4"><label>4</label><mixed-citation publication-type="journal"><person-group><name><surname>Wingenfeld</surname><given-names>K</given-names></name><name><surname>Nutzinger</surname><given-names>D</given-names></name><name><surname>Kauth</surname><given-names>J</given-names></name><etal>et al.</etal></person-group>: <article-title>Salivary cortisol release and hypothalamic pituitary
adrenal axis feedback sensitivity in fibromyalgia is associated with depression but not
with pain</article-title>. <source>J Pain</source>, <year>2010</year>,
<volume>11</volume>: <fpage>1195</fpage>&#x02013;<lpage>1202</lpage>. <pub-id pub-id-type="pmid">20627822</pub-id></mixed-citation></ref><ref id="r5"><label>5</label><mixed-citation publication-type="journal"><person-group><name><surname>Riva</surname><given-names>R</given-names></name><name><surname>Mork</surname><given-names>PJ</given-names></name><name><surname>Westgaard</surname><given-names>RH</given-names></name><etal>et al.</etal></person-group>: <article-title>Fibromyalgia syndrome is associated with
hypocortisolism</article-title>. <source>Int J Behav Med</source>, <year>2010</year>,
<volume>17</volume>: <fpage>223</fpage>&#x02013;<lpage>233</lpage>. <pub-id pub-id-type="pmid">20458566</pub-id></mixed-citation></ref><ref id="r6"><label>6</label><mixed-citation publication-type="journal"><person-group><name><surname>Cuatrecasas</surname><given-names>G</given-names></name><name><surname>Gonzalez</surname><given-names>MJ</given-names></name><name><surname>Alegre</surname><given-names>C</given-names></name><etal>et al.</etal></person-group>: <article-title>High prevalence of growth hormone deficiency in severe
fibromyalgia syndromes</article-title>. <source>J Clin Endocrinol Metab</source>,
<year>2010</year>, <volume>95</volume>: <fpage>4331</fpage>&#x02013;<lpage>4337</lpage>.
<pub-id pub-id-type="pmid">20631018</pub-id></mixed-citation></ref><ref id="r7"><label>7</label><mixed-citation publication-type="journal"><person-group><name><surname>Crofford</surname><given-names>LJ</given-names></name><name><surname>Demitrack</surname><given-names>MA</given-names></name></person-group>: <article-title>Evidence that abnormalities of central neurohormonal
systems are key to understanding fibromyalgia and chronic fatigue
syndrome</article-title>. <source>Rheum Dis Clin North Am</source>, <year>1996</year>,
<volume>22</volume>: <fpage>267</fpage>&#x02013;<lpage>284</lpage>. <pub-id pub-id-type="pmid">8860799</pub-id></mixed-citation></ref><ref id="r8"><label>8</label><mixed-citation publication-type="journal"><person-group><name><surname>Thomas</surname><given-names>EN</given-names></name><name><surname>Blotman</surname><given-names>F</given-names></name></person-group>: <article-title>Aerobic exercise in fibromyalgia: a practical
review</article-title>. <source>Rheumatol Int</source>, <year>2010</year>,
<volume>30</volume>: <fpage>1143</fpage>&#x02013;<lpage>1150</lpage>. <pub-id pub-id-type="pmid">20340025</pub-id></mixed-citation></ref><ref id="r9"><label>9</label><mixed-citation publication-type="journal"><person-group><name><surname>Vural</surname><given-names>M</given-names></name><name><surname>Berkol</surname><given-names>TD</given-names></name><name><surname>Erdogdu</surname><given-names>Z</given-names></name><etal>et al.</etal></person-group>: <article-title>Evaluation of the effectiveness of an aerobic exercise
program and the personality characteristics of patients with fibromyalgia syndrome: a
pilot study</article-title>. <source>J Phys Ther Sci</source>, <year>2014</year>,
<volume>26</volume>: <fpage>1561</fpage>&#x02013;<lpage>1565</lpage>. <pub-id pub-id-type="pmid">25364113</pub-id></mixed-citation></ref><ref id="r10"><label>10</label><mixed-citation publication-type="book"><person-group><name><surname>Kjaer</surname><given-names>M</given-names></name><name><surname>Dela</surname><given-names>FM</given-names></name></person-group>: Endocrine responses to exercise. In: Goetz-Hoffman L, ed. Exercise and
immune function. Florida: CRC Press, <year>1996</year>, pp 1&#x02013;19.</mixed-citation></ref><ref id="r11"><label>11</label><mixed-citation publication-type="journal"><person-group><name><surname>Hill</surname><given-names>EE</given-names></name><name><surname>Zack</surname><given-names>E</given-names></name><name><surname>Battaglini</surname><given-names>C</given-names></name><etal>et al.</etal></person-group>: <article-title>Exercise and circulating cortisol levels: the intensity
threshold effect</article-title>. <source>J Endocrinol Invest</source>,
<year>2008</year>, <volume>31</volume>: <fpage>587</fpage>&#x02013;<lpage>591</lpage>.
<pub-id pub-id-type="pmid">18787373</pub-id></mixed-citation></ref><ref id="r12"><label>12</label><mixed-citation publication-type="journal"><person-group><name><surname>Valim</surname><given-names>V</given-names></name><name><surname>Oliveira</surname><given-names>L</given-names></name><name><surname>Suda</surname><given-names>A</given-names></name><etal>et al.</etal></person-group>: <article-title>Aerobic fitness effects in fibromyalgia</article-title>.
<source>J Rheumatol</source>, <year>2003</year>, <volume>30</volume>:
<fpage>1060</fpage>&#x02013;<lpage>1069</lpage>. <pub-id pub-id-type="pmid">12734907</pub-id></mixed-citation></ref><ref id="r13"><label>13</label><mixed-citation publication-type="journal"><person-group><name><surname>Ortega</surname><given-names>E</given-names></name><name><surname>Garc&#x000ed;a</surname><given-names>JJ</given-names></name><name><surname>Bote</surname><given-names>ME</given-names></name><etal>et al.</etal></person-group>: <article-title>Exercise in fibromyalgia and related inflammatory
disorders: known effects and unknown chances</article-title>. <source>Exerc Immunol
Rev</source>, <year>2009</year>, <volume>15</volume>:
<fpage>42</fpage>&#x02013;<lpage>65</lpage>. <pub-id pub-id-type="pmid">19957871</pub-id></mixed-citation></ref><ref id="r14"><label>14</label><mixed-citation publication-type="journal"><person-group><name><surname>G&#x000fc;rsel</surname><given-names>Y</given-names></name><name><surname>Ergin</surname><given-names>S</given-names></name><name><surname>Ulus</surname><given-names>Y</given-names></name><etal>et al.</etal></person-group>: <article-title>Hormonal responses to exercise stress test in patients
with fibromyalgia syndrome</article-title>. <source>Clin Rheumatol</source>,
<year>2001</year>, <volume>20</volume>: <fpage>401</fpage>&#x02013;<lpage>405</lpage>.
<pub-id pub-id-type="pmid">11771522</pub-id></mixed-citation></ref><ref id="r15"><label>15</label><mixed-citation publication-type="journal"><person-group><name><surname>Wolfe</surname><given-names>F</given-names></name><name><surname>Smythe</surname><given-names>HA</given-names></name><name><surname>Yunus</surname><given-names>MB</given-names></name><etal>et al.</etal></person-group>: <article-title>The American College of Rheumatology 1990 criteria for the
classification of Fibromyalgia. Report of the multicenter criteria
committee</article-title>. <source>Arthritis Rheum</source>, <year>1990</year>,
<volume>33</volume>: <fpage>160</fpage>&#x02013;<lpage>172</lpage>. <pub-id pub-id-type="pmid">2306288</pub-id></mixed-citation></ref><ref id="r16"><label>16</label><mixed-citation publication-type="journal"><person-group><name><surname>Aloisi</surname><given-names>AM</given-names></name><name><surname>Buonocore</surname><given-names>M</given-names></name><name><surname>Merlo</surname><given-names>L</given-names></name><etal>et al.</etal></person-group>: <article-title>Chronic pain therapy and hypothalamic-pituitary-adrenal
axis impairment</article-title>. <source>Psychoneuroendocrinology</source>,
<year>2011</year>, <volume>36</volume>: <fpage>1032</fpage>&#x02013;<lpage>1039</lpage>.
<pub-id pub-id-type="pmid">21256679</pub-id></mixed-citation></ref><ref id="r17"><label>17</label><mixed-citation publication-type="journal"><person-group><name><surname>Burckhardt</surname><given-names>CS</given-names></name><name><surname>Clark</surname><given-names>SR</given-names></name><name><surname>Bennett</surname><given-names>RM</given-names></name></person-group>: <article-title>The fibromyalgia impact questionnaire: development and
validation</article-title>. <source>J Rheumatol</source>, <year>1991</year>,
<volume>18</volume>: <fpage>728</fpage>&#x02013;<lpage>733</lpage>. <pub-id pub-id-type="pmid">1865419</pub-id></mixed-citation></ref><ref id="r18"><label>18</label><mixed-citation publication-type="journal"><person-group><name><surname>Sarmer</surname><given-names>S</given-names></name><name><surname>Ergin</surname><given-names>S</given-names></name><name><surname>Yavuzer</surname><given-names>G</given-names></name></person-group>: <article-title>The validity and reliability of the Turkish version of the
Fibromyalgia Impact Questionnaire</article-title>. <source>Rheumatol Int</source>,
<year>2000</year>, <volume>20</volume>: <fpage>9</fpage>&#x02013;<lpage>12</lpage>.
<pub-id pub-id-type="pmid">11149662</pub-id></mixed-citation></ref><ref id="r19"><label>19</label><mixed-citation publication-type="journal"><person-group><name><surname>Ware</surname><given-names>JE</given-names><suffix>Jr</suffix></name></person-group>: <article-title>SF-36 health survey update</article-title>.
<source>Spine</source>, <year>2000</year>, <volume>25</volume>:
<fpage>3130</fpage>&#x02013;<lpage>3139</lpage>. <pub-id pub-id-type="pmid">11124729</pub-id></mixed-citation></ref><ref id="r20"><label>20</label><mixed-citation publication-type="journal"><person-group><name><surname>Ko&#x000e7;yi&#x0011f;it</surname><given-names>H,</given-names></name></person-group> Aydemir &#x000d6;, Fi&#x0015f;ek G: K&#x00131;sa form-36 (KF-36)&#x02019;n&#x00131;n T&#x000fc;rk&#x000e7;e versiyonunun
g&#x000fc;venirlili&#x0011f;i ve ge&#x000e7;erlili&#x0011f;i. &#x00130;la&#x000e7; ve Tedavi Dergisi, <year>1999,</year> 12:
102&#x02013;106.</mixed-citation></ref><ref id="r21"><label>21</label><mixed-citation publication-type="journal"><person-group><name><surname>Kurtais</surname><given-names>Y</given-names></name><name><surname>Tur</surname><given-names>BS</given-names></name><name><surname>Elhan</surname><given-names>AH</given-names></name><etal>et al.</etal></person-group>: <article-title>Hypothalamic-pituitary-adrenal hormonal responses to
exercise stress test in patients with rheumatoid arthritis compared to healthy
controls</article-title>. <source>J Rheumatol</source>, <year>2006</year>,
<volume>33</volume>: <fpage>1530</fpage>&#x02013;<lpage>1537</lpage>. <pub-id pub-id-type="pmid">16881110</pub-id></mixed-citation></ref><ref id="r22"><label>22</label><mixed-citation publication-type="journal"><person-group><name><surname>Beaver</surname><given-names>WL</given-names></name><name><surname>Wasserman</surname><given-names>K</given-names></name><name><surname>Whipp</surname><given-names>BJ</given-names></name></person-group>: <article-title>A new method for detecting anaerobic threshold by gas
exchange</article-title>. <source>J Appl Physiol 1985</source>, <year>1986</year>,
<volume>60</volume>: <fpage>2020</fpage>&#x02013;<lpage>2027</lpage>. <pub-id pub-id-type="pmid">3087938</pub-id></mixed-citation></ref><ref id="r23"><label>23</label><mixed-citation publication-type="journal"><person-group><name><surname>Arnold</surname><given-names>B</given-names></name><name><surname>H&#x000e4;user</surname><given-names>W</given-names></name><name><surname>Arnold</surname><given-names>M</given-names></name><etal>et al.</etal></person-group>Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen
Fachgesellschaften: <article-title>[Multicomponent therapy of fibromyalgia syndrome.
Systematic review, meta-analysis and guideline]</article-title>.
<source>Schmerz</source>, <year>2012</year>, <volume>26</volume>:
<fpage>287</fpage>&#x02013;<lpage>290</lpage>. <pub-id pub-id-type="pmid">22760461</pub-id></mixed-citation></ref><ref id="r24"><label>24</label><mixed-citation publication-type="journal"><person-group><name><surname>Mannerkorpi</surname><given-names>K</given-names></name><name><surname>Nordeman</surname><given-names>L</given-names></name><name><surname>Cider</surname><given-names>A</given-names></name><etal>et al.</etal></person-group>: <article-title>Does moderate-to-high intensity Nordic walking improve
functional capacity and pain in fibromyalgia? A prospective randomized controlled
trial</article-title>. <source>Arthritis Res Ther</source>, <year>2010</year>,
<volume>12</volume>: <fpage>R189</fpage>. <pub-id pub-id-type="pmid">20942911</pub-id></mixed-citation></ref><ref id="r25"><label>25</label><mixed-citation publication-type="journal"><person-group><name><surname>Bircan</surname><given-names>C</given-names></name><name><surname>Karasel</surname><given-names>SA</given-names></name><name><surname>Akg&#x000fc;n</surname><given-names>B</given-names></name><etal>et al.</etal></person-group>: <article-title>Effects of muscle strengthening versus aerobic exercise
program in fibromyalgia</article-title>. <source>Rheumatol Int</source>,
<year>2008</year>, <volume>28</volume>: <fpage>527</fpage>&#x02013;<lpage>532</lpage>.
<pub-id pub-id-type="pmid">17982749</pub-id></mixed-citation></ref><ref id="r26"><label>26</label><mixed-citation publication-type="journal"><person-group><name><surname>Mengshoel</surname><given-names>AM</given-names></name><name><surname>Komnaes</surname><given-names>HB</given-names></name><name><surname>F&#x000f8;rre</surname><given-names>O</given-names></name></person-group>: <article-title>The effects of 20 weeks of physical fitness training in
female patients with fibromyalgia</article-title>. <source>Clin Exp Rheumatol</source>,
<year>1992</year>, <volume>10</volume>: <fpage>345</fpage>&#x02013;<lpage>349</lpage>.
<pub-id pub-id-type="pmid">1395219</pub-id></mixed-citation></ref><ref id="r27"><label>27</label><mixed-citation publication-type="journal"><person-group><name><surname>Ross</surname><given-names>RL</given-names></name><name><surname>Jones</surname><given-names>KD</given-names></name><name><surname>Bennett</surname><given-names>RM</given-names></name><etal>et al.</etal></person-group>: <article-title>Preliminary evidence of increased pain and elevated
cytokines in fibromyalgia patients with defective growth hormone response to
exercise</article-title>. <source>Open Immunol J</source>, <year>2010</year>,
<volume>3</volume>: <fpage>9</fpage>&#x02013;<lpage>18</lpage>. <pub-id pub-id-type="pmid">20467575</pub-id></mixed-citation></ref><ref id="r28"><label>28</label><mixed-citation publication-type="journal"><person-group><name><surname>Mehta</surname><given-names>A</given-names></name><name><surname>Hindmarsh</surname><given-names>PC</given-names></name></person-group>: <article-title>The use of somatropin (recombinant growth hormone) in
children of short stature</article-title>. <source>Paediatr Drugs</source>,
<year>2002</year>, <volume>4</volume>: <fpage>37</fpage>&#x02013;<lpage>47</lpage>.
<pub-id pub-id-type="pmid">11817985</pub-id></mixed-citation></ref><ref id="r29"><label>29</label><mixed-citation publication-type="journal"><person-group><name><surname>Moldofsky</surname><given-names>H</given-names></name><name><surname>Scarisbrick</surname><given-names>P</given-names></name><name><surname>England</surname><given-names>R</given-names></name><etal>et al.</etal></person-group>: <article-title>Musculosketal symptoms and non-REM sleep disturbance in
patients with &#x0201c;fibrositis syndrome&#x0201d; and healthy subjects</article-title>.
<source>Psychosom Med</source>, <year>1975</year>, <volume>37</volume>:
<fpage>341</fpage>&#x02013;<lpage>351</lpage>. <pub-id pub-id-type="pmid">169541</pub-id></mixed-citation></ref><ref id="r30"><label>30</label><mixed-citation publication-type="journal"><person-group><name><surname>Jones</surname><given-names>KD</given-names></name><name><surname>Deodhar</surname><given-names>P</given-names></name><name><surname>Lorentzen</surname><given-names>A</given-names></name><etal>et al.</etal></person-group>: <article-title>Growth hormone perturbations in fibromyalgia: a
review</article-title>. <source>Semin Arthritis Rheum</source>, <year>2007</year>,
<volume>36</volume>: <fpage>357</fpage>&#x02013;<lpage>379</lpage>. <pub-id pub-id-type="pmid">17224178</pub-id></mixed-citation></ref><ref id="r31"><label>31</label><mixed-citation publication-type="journal"><person-group><name><surname>Jacobsen</surname><given-names>S</given-names></name><name><surname>Main</surname><given-names>K</given-names></name><name><surname>Danneskiold-Sams&#x000f8;e</surname><given-names>B</given-names></name><etal>et al.</etal></person-group>: <article-title>A controlled study on serum insulin-like growth factor-I
and urinary excretion of growth hormone in fibromyalgia</article-title>. <source>J
Rheumatol</source>, <year>1995</year>, <volume>22</volume>:
<fpage>1138</fpage>&#x02013;<lpage>1140</lpage>. <pub-id pub-id-type="pmid">7674243</pub-id></mixed-citation></ref><ref id="r32"><label>32</label><mixed-citation publication-type="journal"><person-group><name><surname>Buchwald</surname><given-names>D</given-names></name><name><surname>Umali</surname><given-names>J</given-names></name><name><surname>Stene</surname><given-names>M</given-names></name></person-group>: <article-title>Insulin-like growth factor-I (somatomedin C) levels in
chronic fatigue syndrome and fibromyalgia</article-title>. <source>J Rheumatol</source>,
<year>1996</year>, <volume>23</volume>: <fpage>739</fpage>&#x02013;<lpage>742</lpage>.
<pub-id pub-id-type="pmid">8730136</pub-id></mixed-citation></ref><ref id="r33"><label>33</label><mixed-citation publication-type="journal"><person-group><name><surname>Berg</surname><given-names>U</given-names></name><name><surname>Bang</surname><given-names>P</given-names></name></person-group>: <article-title>Exercise and circulating insulin-like growth factor
I</article-title>. <source>Horm Res</source>, <year>2004</year>, <volume>62</volume>:
<fpage>50</fpage>&#x02013;<lpage>58</lpage>. <pub-id pub-id-type="pmid">15761233</pub-id></mixed-citation></ref><ref id="r34"><label>34</label><mixed-citation publication-type="journal"><person-group><name><surname>Jones</surname><given-names>KD</given-names></name><name><surname>Deodhar</surname><given-names>AA</given-names></name><name><surname>Burckhardt</surname><given-names>CS</given-names></name><etal>et al.</etal></person-group>: <article-title>A combination of 6 months of treatment with pyridostigmine
and triweekly exercise fails to improve insulin-like growth factor-I levels in
fibromyalgia, despite improvement in the acute growth hormone response to
exercise</article-title>. <source>J Rheumatol</source>, <year>2007</year>,
<volume>34</volume>: <fpage>1103</fpage>&#x02013;<lpage>1111</lpage>. <pub-id pub-id-type="pmid">17407215</pub-id></mixed-citation></ref><ref id="r35"><label>35</label><mixed-citation publication-type="journal"><person-group><name><surname>Kirnap</surname><given-names>M</given-names></name><name><surname>Colak</surname><given-names>R</given-names></name><name><surname>Eser</surname><given-names>C</given-names></name><etal>et al.</etal></person-group>: <article-title>A comparison between low-dose (1 microg), standard-dose
(250 microg) ACTH stimulation tests and insulin tolerance test in the evaluation of
hypothalamo-pituitary-adrenal axis in primary fibromyalgia syndrome</article-title>.
<source>Clin Endocrinol (Oxf)</source>, <year>2001</year>, <volume>55</volume>:
<fpage>455</fpage>&#x02013;<lpage>459</lpage>. <pub-id pub-id-type="pmid">11678827</pub-id></mixed-citation></ref><ref id="r36"><label>36</label><mixed-citation publication-type="journal"><person-group><name><surname>Riedel</surname><given-names>W</given-names></name><name><surname>Layka</surname><given-names>H</given-names></name><name><surname>Neeck</surname><given-names>G</given-names></name></person-group>: <article-title>Secretory pattern of GH, TSH, thyroid hormones, ACTH,
cortisol, FSH, and LH in patients with fibromyalgia syndrome following systemic
injection of the relevant hypothalamic-releasing hormones</article-title>. <source>Z
Rheumatol</source>, <year>1998</year>, <volume>57</volume>:
<fpage>81</fpage>&#x02013;<lpage>87</lpage>. <pub-id pub-id-type="pmid">10025090</pub-id></mixed-citation></ref><ref id="r37"><label>37</label><mixed-citation publication-type="journal"><person-group><name><surname>Riedel</surname><given-names>W</given-names></name><name><surname>Schlapp</surname><given-names>U</given-names></name><name><surname>Leck</surname><given-names>S</given-names></name><etal>et al.</etal></person-group>: <article-title>Blunted ACTH and cortisol responses to systemic injection
of corticotropin-releasing hormone (CRH) in fibromyalgia: role of somatostatin and
CRH-binding protein</article-title>. <source>Ann N Y Acad Sci</source>,
<year>2002</year>, <volume>966</volume>: <fpage>483</fpage>&#x02013;<lpage>490</lpage>.
<pub-id pub-id-type="pmid">12114308</pub-id></mixed-citation></ref><ref id="r38"><label>38</label><mixed-citation publication-type="journal"><person-group><name><surname>Wingenfeld</surname><given-names>K</given-names></name><name><surname>Heim</surname><given-names>C</given-names></name><name><surname>Schmidt</surname><given-names>I</given-names></name><etal>et al.</etal></person-group>: <article-title>HPA axis reactivity and lymphocyte glucocorticoid
sensitivity in fibromyalgia syndrome and chronic pelvic pain</article-title>.
<source>Psychosom Med</source>, <year>2008</year>, <volume>70</volume>:
<fpage>65</fpage>&#x02013;<lpage>72</lpage>. <pub-id pub-id-type="pmid">18158367</pub-id></mixed-citation></ref><ref id="r39"><label>39</label><mixed-citation publication-type="journal"><person-group><name><surname>Catley</surname><given-names>D</given-names></name><name><surname>Kaell</surname><given-names>AT</given-names></name><name><surname>Kirschbaum</surname><given-names>C</given-names></name><etal>et al.</etal></person-group>: <article-title>A naturalistic evaluation of cortisol secretion in persons
with fibromyalgia and rheumatoid arthritis</article-title>. <source>Arthritis Care
Res</source>, <year>2000</year>, <volume>13</volume>:
<fpage>51</fpage>&#x02013;<lpage>61</lpage>. <pub-id pub-id-type="pmid">11094926</pub-id></mixed-citation></ref><ref id="r40"><label>40</label><mixed-citation publication-type="journal"><person-group><name><surname>Gur</surname><given-names>A</given-names></name><name><surname>Cevik</surname><given-names>R</given-names></name><name><surname>Sarac</surname><given-names>AJ</given-names></name><etal>et al.</etal></person-group>: <article-title>Hypothalamic-pituitary-gonadal axis and cortisol in young
women with primary fibromyalgia: the potential roles of depression, fatigue, and sleep
disturbance in the occurrence of hypocortisolism</article-title>. <source>Ann Rheum
Dis</source>, <year>2004</year>, <volume>63</volume>:
<fpage>1504</fpage>&#x02013;<lpage>1506</lpage>. <pub-id pub-id-type="pmid">15479904</pub-id></mixed-citation></ref><ref id="r41"><label>41</label><mixed-citation publication-type="journal"><person-group><name><surname>Maes</surname><given-names>M</given-names></name><name><surname>Lin</surname><given-names>A</given-names></name><name><surname>Bonaccorso</surname><given-names>S</given-names></name><etal>et al.</etal></person-group>: <article-title>Increased 24-hour urinary cortisol excretion in patients
with post-traumatic stress disorder and patients with major depression, but not in
patients with fibromyalgia</article-title>. <source>Acta Psychiatr Scand</source>,
<year>1998</year>, <volume>98</volume>: <fpage>328</fpage>&#x02013;<lpage>335</lpage>.
<pub-id pub-id-type="pmid">9821456</pub-id></mixed-citation></ref><ref id="r42"><label>42</label><mixed-citation publication-type="journal"><person-group><name><surname>McLean</surname><given-names>SA</given-names></name><name><surname>Williams</surname><given-names>DA</given-names></name><name><surname>Harris</surname><given-names>RE</given-names></name><etal>et al.</etal></person-group>: <article-title>Momentary relationship between cortisol secretion and
symptoms in patients with fibromyalgia</article-title>. <source>Arthritis
Rheum</source>, <year>2005</year>, <volume>52</volume>:
<fpage>3660</fpage>&#x02013;<lpage>3669</lpage>. <pub-id pub-id-type="pmid">16258904</pub-id></mixed-citation></ref><ref id="r43"><label>43</label><mixed-citation publication-type="journal"><person-group><name><surname>Pollock</surname><given-names>M</given-names></name><name><surname>Gaesser</surname><given-names>GA</given-names></name><name><surname>Butcher</surname><given-names>JD</given-names></name><etal>et al.</etal></person-group>: <article-title>The recommend quantity and quality of exercise for
developing and maintaining cardiorespiratory and muscular fitness, and flexibility in
healthy adults</article-title>. <source>Med Sci Sports Exerc</source>,
<year>1998</year>, <volume>30</volume>: <fpage>975</fpage>&#x02013;<lpage>991</lpage>.
<pub-id pub-id-type="pmid">9624661</pub-id></mixed-citation></ref></ref-list></back></article>